AR040521A1 - Gen sisntetico que codifica al factor estimulante de colonias de granulocitos humano para la expresion e. coli - Google Patents
Gen sisntetico que codifica al factor estimulante de colonias de granulocitos humano para la expresion e. coliInfo
- Publication number
- AR040521A1 AR040521A1 AR20030102715A ARP030102715A AR040521A1 AR 040521 A1 AR040521 A1 AR 040521A1 AR 20030102715 A AR20030102715 A AR 20030102715A AR P030102715 A ARP030102715 A AR P030102715A AR 040521 A1 AR040521 A1 AR 040521A1
- Authority
- AR
- Argentina
- Prior art keywords
- expression
- coli
- granulocit
- codifying
- colonies
- Prior art date
Links
- 241000588724 Escherichia coli Species 0.000 title abstract 2
- 230000004936 stimulating effect Effects 0.000 title 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 108700005078 Synthetic Genes Proteins 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se refiere al gen sintético que codifica al hG-CSF que permite la expresión en E. Coli con un nivel de expresión mejorado del hG-CSF recombinante respecto de las proteínas celulares totales después de la expresión. Reivindicación 1:Una secuencia de ADN que codifica al hG-CSF caracterizada porque la secuencia comprende la secuencia nucleótida de la SEC ID NO:1.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SI200200188A SI21272A (sl) | 2002-07-31 | 2002-07-31 | Sintetski gen za humani granulocitne kolonije stimulirajoči dejavnik za ekspresijo v E. coli |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR040521A1 true AR040521A1 (es) | 2005-04-06 |
Family
ID=31493133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR20030102715A AR040521A1 (es) | 2002-07-31 | 2003-07-29 | Gen sisntetico que codifica al factor estimulante de colonias de granulocitos humano para la expresion e. coli |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7655437B2 (es) |
| EP (1) | EP1527095A1 (es) |
| JP (1) | JP4445466B2 (es) |
| AR (1) | AR040521A1 (es) |
| AU (1) | AU2003253344A1 (es) |
| SI (1) | SI21272A (es) |
| WO (1) | WO2004013175A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2639301T3 (es) | 2003-04-30 | 2017-10-26 | Universität Zürich | Procedimientos de tratamiento de cáncer usando una inmunotoxina |
| WO2008128330A1 (en) * | 2007-04-19 | 2008-10-30 | Viventia Biotech Inc. | Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins |
| WO2009039630A1 (en) * | 2007-09-27 | 2009-04-02 | Viventia Biotech Inc. | Optimized nucleic acid sequences for the expression of vb4-845 |
| RU2529363C2 (ru) * | 2011-03-02 | 2014-09-27 | Общество с ограниченной ответственностью "Научно-Технологический Центр "БиоИнвест" | РЕКОМБИНАНТНАЯ ДНК, КОДИРУЮЩАЯ ГРАНУЛОЦИТАРНЫЙ КОЛОНИЕСТИМУЛИРУЮЩИЙ ФАКТОР ЧЕЛОВЕКА (G-CSF) И РЕКОМБИНАНТНАЯ ПЛАЗМИДА рAS017, ОБЕСПЕЧИВАЮЩАЯ СИНТЕЗ G-CSF В КЛЕТКАХ Escherichia coli |
| RU2016116549A (ru) | 2013-10-02 | 2017-11-09 | Вивентиа Био Инк. | Антитела против epcam и способы их применения |
| CA2979400A1 (en) | 2015-03-12 | 2016-09-15 | Viventia Bio Inc. | Dosing strategies for targeting epcam positive bladder cancer |
| WO2016145349A1 (en) | 2015-03-12 | 2016-09-15 | Viventia Bio Inc. | Methods of treatment for epcam positive bladder cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9004390D0 (en) * | 1990-02-27 | 1990-04-25 | Ici Plc | Process |
-
2002
- 2002-07-31 SI SI200200188A patent/SI21272A/sl not_active IP Right Cessation
-
2003
- 2003-07-28 EP EP03766320A patent/EP1527095A1/en not_active Withdrawn
- 2003-07-28 JP JP2005506069A patent/JP4445466B2/ja not_active Expired - Lifetime
- 2003-07-28 AU AU2003253344A patent/AU2003253344A1/en not_active Abandoned
- 2003-07-28 US US10/522,827 patent/US7655437B2/en not_active Expired - Fee Related
- 2003-07-28 WO PCT/EP2003/008308 patent/WO2004013175A1/en not_active Ceased
- 2003-07-29 AR AR20030102715A patent/AR040521A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI21272A (sl) | 2004-02-29 |
| US20060228781A1 (en) | 2006-10-12 |
| JP2006512089A (ja) | 2006-04-13 |
| WO2004013175A1 (en) | 2004-02-12 |
| EP1527095A1 (en) | 2005-05-04 |
| JP4445466B2 (ja) | 2010-04-07 |
| US7655437B2 (en) | 2010-02-02 |
| AU2003253344A1 (en) | 2004-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR047347A1 (es) | Miembros de la familia cry9 de bacillus | |
| AU9096001A (en) | G-csf analog compositions and methods | |
| MX353906B (es) | Metodo para la produccion de acidos grasos poli-insaturados en organismos transgenicos. | |
| CY1112924T1 (el) | Κυτταροδιαπερατοι αναστολεις της jnk-σηματοδοτικης πορειας μεταγωγης | |
| ATE352626T1 (de) | Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren | |
| SG151315A1 (en) | Human glp-1 mimetibodies, compositions, methods and uses | |
| ES2059354T3 (es) | Un metodo para producir un polipeptido. | |
| BR112022006842A2 (pt) | Construtos de igf2 variante | |
| CY1110868T1 (el) | Ελαχιστη αλληλουχια dna που δρα ως μονωτης της χρωματινης και η χρηση της στην πρωτεϊνικη εκφραση | |
| DE60329382D1 (de) | Kostengünstige herstellung von peptiden | |
| DK0981630T3 (da) | Polypeptider med prolyldipeptidylaminopeptidaseaktivitet og nukleinsyrer, der koder for samme | |
| CY1114526T1 (el) | Κατασταλτικες πρωτεϊνες μιας πρωτεασης (protease) και χρησεις αυτων | |
| AR016436A1 (es) | Proteina que inhibe a la p27, adn que la codifica, anticuerpos y productos de disociacion de los mismos, acido nucleico antisentido, estructura artificialde acido nucleico y la utilizacion de todo esto en terapia y profilaxis de enfermedades | |
| AR040521A1 (es) | Gen sisntetico que codifica al factor estimulante de colonias de granulocitos humano para la expresion e. coli | |
| ES2489715T3 (es) | Procedimiento para la produccíón de colágeno humano de tipo II | |
| DK1290160T3 (da) | Humane Pellino-polypeptider | |
| NZ562436A (en) | Toll-like receptor 14 (TLR14) and use thereof | |
| PT914419E (pt) | Ratinhos transgenicos capazes de expressar o factor de inibicao de leucemia | |
| DE60235985D1 (de) | Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk) | |
| AR045000A1 (es) | Gen y proteina de eimeria , y su uso | |
| ATE533779T1 (de) | Isoliertes photoprotein mtclytin, sowie dessen verwendung | |
| AR015757A1 (es) | Fragmento aislado de acidos nucleicos que codifica toda o una porcion sustancial de proteinas reguladoras del ciclo celular en plantas y semillas, genquimerico, celula huesped transformada, polipeptido, metodo para alterar el nivel de expresion de dicha proteina, metodo para obtener dicho fragmento | |
| AU2003260452A8 (en) | Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells | |
| ATE370964T1 (de) | Isoliertes fluoreszierendes protein aus clytia gregaria cgfp, sowie dessen verwendung | |
| ATE303444T1 (de) | Nukleinsäuren kodierend für das tmk gen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |